
Industry Focus Transcripts
Articles — Page 49


Aug 1, 2018 by Todd Campbell
Here's What's Going On at Eli Lilly and GlaxoSmithKline
It’s big pharma week! First, we discuss Eli Lilly’s second-quarter earnings and its decision to spin off its animal health business. Then, we explain why GlaxoSmithKline became an investor in the DNA screening company 23andMe.

















